“…Several studies confirm that SIRT1 activity promotes eNOS expression/activity and improves endothelial cell survival and function (Lagouge et al , ; Mattagajasingh et al , ; Zhang et al , ). Clinical trials are underway to examine the potential benefits of resveratrol administration in subjects with cardiovascular disorders (Schleithoff et al , ; Xia et al , ). However, there are still unsolved safety concerns regarding the chronic consumption of high resveratrol doses (Tome‐Carneiro et al , ).…”